Helping select the right medication, at the right dose for you
BasePair Genomics is proud to be the Australian service provider of CNSDose, a second-generation pharmacogenomics test to improve antidepressant prescribing. Reduce “trial and error” prescribing through evidence-based pharmacogenomics.
For more information about CNSDose click the link below:
BasePair Genomics is an Australian molecular diagnostics company providing genetic testing for clinical, research and commercial clients. We are dedicated to improving healthcare and supporting personalized medicine initiatives through our pharmacogenomics expertise.